Of the 189 sporadic NF2-altered meningiomas, 80.9% were WHO grade I (meningothelial: 39.7%, transitional/fibrous: 39.2%, others: 2.1%) and 19.1% were WHO grade II/III (Fig. 1C, Table 1). This evidence concerns the gene NF2 and meningioma.